Cancer therapy developer Artiva Biotherapeutics files to hold IPO on Nasdaq
By Val Kennedy, Artiva Biotherapeutics (ARTV), which is developing cell-based therapies to treat cancer, has filed to hold an initial...
Pre IPO Swap
California VC firm backed by Russia navigates a global crisis
From Pitchbook For Fort Ross Ventures, a Silicon Valley firm with strong ties to Russia, the war in Ukraine casts a...
Infectious disease biotech Alopexx files for a $17 million IPO
By Renaissance Capital, Alopexx, a Phase 2 biotech developing immune therapies for bacterial, fungal, and parasitic infections, filed on Monday...
Indian online marketplace Meesho reportedly eyeing US IPO
By Val Kennedy, Indian e-commerce platform Meesho, which was recently valued at close to $5B, is reportedly eyeing an initial...
Biotech AN2 Therapeutics files for IPO, developing treatment for rare lung disease
By Val Kennedy, Biotech group AN2 Therapeutics (ANTX) has filed to hold an initial public offering to help fund development...
Talkdesk said to file confidentially for U.S. IPO
By Joshua Fineman, Talkdesk, a maker of cloud-based call center software, is said to be preparing for a U.S. initial...
Chinese SPAC Jeneration Acquisition pulls plans for $300M US IPO
By Val Kennedy, Chinese SPAC Jeneration Acquisition (JACAU) has withdrawn plans to hold a US initial public offering to raise...
Peter Thiel-backed fintech N26 reportedly eyeing IPO
By Val Kennedy, Peter Thiel-backed German neobank N26 is reportedly eyeing an initial public offering in 2024. N26 Co-Chief Executive...
mPhase Technologies looks to uplist shares, conduct offering on Nasdaq
By Val Kennedy, Mphase Technologies (OTCPK:XDSL) has filed to uplist its shares from the over-the-counter market and raise additional cash through an...
SPAC Heroic Empire Acquisition files for a $75 million IPO, targeting biotechnology or TMT
By Renaissance Capital, Heroic Empire Acquisition, a blank check company targeting the biotechnology or TMT industries, filed on Friday with...
